Stay updated on Imsidolimab in Generalized Pustular Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Imsidolimab in Generalized Pustular Psoriasis Clinical Trial page.

Latest updates to the Imsidolimab in Generalized Pustular Psoriasis Clinical Trial page
- ChecktodayChange DetectedRevision label updated from v3.3.3 to v3.3.4 on the Study Details page with no changes to study data, eligibility criteria, outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedA consolidated Locations section is added, listing California, Florida, Indiana, and Michigan; state-specific entries are removed, with the revision tag updated from v3.3.2 to v3.3.3.SummaryDifference0.5%

- Check50 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2; no changes to study content or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check57 days agoChange DetectedThe notice about government funding and potential delays has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check71 days agoChange DetectedThe updates appear limited to formatting, dates, and minor UI sections; no changes to core study details or eligibility criteria are observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check100 days agoChange DetectedUpgrade to v3.2.0 with an inserted government operating status notice; previous version v3.1.0 removed.SummaryDifference4%

Stay in the know with updates to Imsidolimab in Generalized Pustular Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Imsidolimab in Generalized Pustular Psoriasis Clinical Trial page.